Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Collaborations & Alliances •
Evotec Achieves Twelfth Boehringer Milestone

May 9, 2011
Evotec AG has achieved a twelfth milestone in its research alliance with Boehringer Ingelheim triggering a $2.9 million payment to Evotec.   Read More »
Pfizer’s Prevnar 13 Meets Phase III Endpoints

May 9, 2011
Pfizer met all study endpoints in two Phase III immunogenicity and safety trials of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) in adults aged 50 years and older.  Read More »
Myoderm Expands in European Market

May 6, 2011
Myoderm has been granted a Wholesale Dealer License from the Medicines and Healthcare products Regulatory Agency (MHRA), expanding its position within the European pharmaceutical market.  Read More »
Quotient Clinical Completes Expansion

May 6, 2011
Quotient Clinical, a business unit of Quotient Bioresearch, has completed a major expansion of its clinical facilities in Nottingham, UK.   Read More »
Penn Pharma

May 6, 2011
Mark Dean-Netscher has been appointed chief operating officer of Penn Pharma, effective May 16th.  Read More »
Axcan Pharma, Eurand Renamed Aptalis Pharma

May 6, 2011
Axcan Pharma Holding B.V. and Eurand N.V., have renamed of their combined companies to Aptalis Pharma.   Read More »
Almac Clinical Technologies

May 6, 2011
Todd Kole has been named vice president of Clinical Project Services (CPS) and a member of the Executive Leadership Team at Almac Clinical Technologies.  Read More »
INC Research To Acquire Kendle

May 5, 2011
INC Research has entered a definitive merger agreement to acquire Kendle International for approximately $232 million in cash.  Read More »
Financial Report: Covance 1Q11

May 5, 2011
Early Development revenues were $224.0 million (+9%).   Read More »
SCM Pharma Gets Aseptic Fill Project

May 5, 2011
SCM Pharma has secured a sterile filling and packaging project with Molteni Therapeutics, a specialty pharmaceutical company based in Italy, for a new drug substance in development for the topical treatment of infected skin lesions using the PhotoDynamic   Read More »
CMC Biologics

May 5, 2011
Claes Glassell has been appointed chief executive officer of CMC Biologics.  Read More »
Catalent Pharma Solutions

May 4, 2011
Pfizer, Wyeth vet to take role over R&D and technology programs  Read More »
Frontage, BSPC Get FDA Approval for Generic Norvasc

May 4, 2011
Beijing Second Pharmaceutical Co., Ltd. (BSPC) has received FDA approval of its ANDA 090752 for Amlodipine Besylate, a generic form of Pfizer’s Norvasc.   Read More »
Charles River Laboratories 1Q11

May 4, 2011
Sales were down 7% in the Preclinical Services (PCS) segment to $112.5 million.  Read More »
AMRI 1Q11

May 4, 2011
Contract revenue in the quarter was $42.9 million, up 10%.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: